Skip Navigation

Exhibit 300 (BY2009) for FDA Financial Enterprise Solutions (FES)

PART ONE


OVERVIEW


1. Date of Submission:
2008-02-04
2. Agency:
009
3. Bureau:
10
4. Name of this Capital Asset:
FDA Financial Enterprise Solutions (FES) (FY09)
5. Unique Project Identifier:
009-10-01-01-01-7068-00
6. What kind of investment will this be in FY2009?
Mixed Life Cycle
7. What was the first budget year this investment was submitted to OMB?
FY2005
8. Provide a brief summary and justification for this investment, including a brief description of how this closes in part or in whole an identified agency performance gap.
MISSION SUPPORT: DHHS and FDA missions depend upon efficient and effective use of public funds. Financial management ensures control and accounting of public funds, enforces administrative spending controls and standardizes transactions. FES integrates with the HHS Unified Financial Management System (UFMS) and supports over 10,000 FDA employees. FES is Mission Critical. PART remediation and financial performance gaps addressed are: Improve Financial Performance - FES ensures that allocated public funds support the FDA mission with fiduciary integrity in compliance with applicable laws, accounting standards and federal guidelines through administrative spending controls while reducing costs and improving efficiency of financial management processes. Process automation replaces or eliminates many manual tasks. Eliminate redundancies and increase collaboration - FDA 2002 & 2003 eGovernment strategy reviews identified duplicate IT systems in FDA Centers. Example: National Center for Toxicological Research (NCTR) had a Contracts and Procurement Support System (CAPSS) to generate task orders and delivery orders similar to FES PRISM. Other Centers had duplicate manual processes for the same purpose. Use of FES PRISM as a standard procurement document generator and workflow manager eliminated redundancies and fostered collaboration across Centers. Bring Technology to Bear to Improve Services to Citizens - Financial systems are enablers for delivery of Services to Citizens. Example: FES PRISM provides faster, less costly automated processing of procurement orders for medical research supplies critical to public health research. HHS UFMS supports the production of financial statements and financial reporting. FES works with UFMS bringing technology to bear in financial systems that enable and, ultimately, result in improved health-related services to citizens. GOAL SUPPORT: FES reduced requirements for an estimated 22 full-time staff and supports the DHHS Strategic Goal to Achieve Excellence in Management Practices, the FDA Strategic Goal - A Strong FDA, and Outcome Goal - Reduce administrative overhead by reducing the number of administrative staff. Currently development (Financial Reporting, User Fees) and maintenance (AMS, Financial Reporting, PRISM) projects managed by the FDA Office of Financial Management (OFM) are included. FDA funding for HHS global financial IT are not funded by FES.
9. Did the Agency's Executive/Investment Committee approve this request?
yes
9.a. If "yes," what was the date of this approval?
2007-06-23
10. Did the Project Manager review this Exhibit?
yes
11.a. What is the current FAC-P/PM certification level of the project/program manager?
Senior/Expert-level
12. Has the agency developed and/or promoted cost effective, energy-efficient and environmentally sustainable techniques or practices for this project.
yes
12.a. Will this investment include electronic assets (including computers)?
yes
12.b. Is this investment for new construction or major retrofit of a Federal building or facility? (answer applicable to non-IT assets only)
no
13. Does this investment directly support one of the PMA initiatives?
yes
If yes, select the initiatives that apply:
Initiative Name
Financial Performance
13.a. Briefly and specifically describe for each selected how this asset directly supports the identified initiative(s)? (e.g. If E-Gov is selected, is it an approved shared service provider or the managing partner?)
FES provides FDA organizations with financial controls, oversight, management and reporting. FES aligns with the Financial Performance initiative by integrating financial data with performance information, improving the quality and timeliness of Federal financial data and providing summary financial data that is auditable at the transaction level for FDA. Through FES, FDA has received clean audit opinions for seven years and zero reportable material weaknesses in financial reporting to HHS.
14. Does this investment support a program assessed using the Program Assessment Rating Tool (PART)?
yes
14.a. If yes, does this investment address a weakness found during the PART review?
no
14.b. If yes, what is the name of the PARTed program?
2005: FDA - Overall FDA
14.c. If yes, what rating did the PART receive?
Moderately Effective
15. Is this investment for information technology?
yes
16. What is the level of the IT Project (per CIO Council's PM Guidance)?
Level 2
17. What project management qualifications does the Project Manager have? (per CIO Council's PM Guidance)
(1) Project manager has been validated as qualified for this investment
18. Is this investment identified as high risk on the Q4 - FY 2007 agency high risk report (per OMB memorandum M-05-23)?
no
19. Is this a financial management system?
yes
19.a. If yes, does this investment address a FFMIA compliance area?
yes
19.a.1. If yes, which compliance area:
Financial Systems and Processes
19.b. If yes, please identify the system name(s) and system acronym(s) as reported in the most recent financial systems inventory update required by Circular A11 section 52.
Financial Enterprise Solutions (FES)
20. What is the percentage breakout for the total FY2009 funding request for the following? (This should total 100%)
AreaPercentage
Hardware0
Software13
Services70
Other17
21. If this project produces information dissemination products for the public, are these products published to the Internet in conformance with OMB Memorandum 05-04 and included in your agency inventory, schedules and priorities?
n/a
22. Contact information of individual responsible for privacy related questions.
NameBetty Dorsey
Phone Number301 827 6567
TitleFDA Privacy Act Officer
Emailbetty.dorsey@fda.hhs.gov
23. Are the records produced by this investment appropriately scheduled with the National Archives and Records Administration's approval?
yes
24. Does this investment directly support one of the GAO High Risk Areas?
no

SUMMARY OF SPEND


1. Provide the total estimated life-cycle cost for this investment by completing the following table. All amounts represent budget authority in millions, and are rounded to three decimal places. Federal personnel costs should be included only in the row designated Government FTE Cost, and should be excluded from the amounts shown for Planning, Full Acquisition, and Operation/Maintenance. The total estimated annual cost of the investment is the sum of costs for Planning, Full Acquisition, and Operation/Maintenance. For Federal buildings and facilities, life-cycle costs should include long term energy, environmental, decommissioning, and/or restoration costs. The costs associated with the entire life-cycle of the investment should be included in this report.

All amounts represent Budget Authority

Note: For the cross-agency investments, this table should include all funding (both managing partner and partner agencies).

Government FTE Costs should not be included as part of the TOTAL represented.
Cost TypePy-1 & Earlier
-2006
PY
2007
CY
2008
BY
2009
Planning Budgetary Resources0.0000.0000.0000.000
Acquisition Budgetary Resources4.7563.4740.1500.000
Maintenance Budgetary Resources42.03812.9897.9255.559
Government FTE Cost9.6760.7520.5930.463
# of FTEs4444
2. Will this project require the agency to hire additional FTE's?
no
3. If the summary of spending has changed from the FY2008 President's budget request, briefly explain those changes.
Additions of approved DME activities and shifts in planned work to earlier fiscal periods for the FDA Financial Enterprise Solutions (FES), Major IT investment have resulted in changes to the investment phase from Steady State to Mixed-Life Cycle for FY2007 and FY2008. Changes are documented in a pending rebaseline request with approval expected in August 2007 and result in the following updates to spending plans for the investment: FY2007 increased spending of 52% ($ 5.897M) . FY2008 decreased spending of 15% ($ 1.567M). FY2009 decreased spending of 48% ($ 5.638M).

PERFORMANCE


In order to successfully address this area of the exhibit 300, performance goals must be provided for the agency and be linked to the annual performance plan. The investment must discuss the agency's mission and strategic goals, and performance measures (indicators) must be provided. These goals need to map to the gap in the agency's strategic goals and objectives this investment is designed to fill. They are the internal and external performance benefits this investment is expected to deliver to the agency (e.g., improve efficiency by 60 percent, increase citizen participation by 300 percent a year to achieve an overall citizen participation rate of 75 percent by FY 2xxx, etc.). The goals must be clearly measurable investment outcomes, and if applicable, investment outputs. They do not include the completion date of the module, milestones, or investment, or general goals, such as, significant, better, improved that do not have a quantitative measure.
Agencies must use the following table to report performance goals and measures for the major investment and use the Federal Enterprise Architecture (FEA) Performance Reference Model (PRM). Map all Measurement Indicators to the corresponding Measurement Area and Measurement Grouping identified in the PRM. There should be at least one Measurement Indicator for each of the four different Measurement Areas (for each fiscal year). The PRM is available at www.egov.gov. The table can be extended to include performance measures for years beyond FY 2009.
RowFiscal YearStrategic Goal SupportedMeasurement AreaMeasurement GroupingMeasurement IndicatorBaselinePlanned Improvement to the BaselineActual Results
12006Effective Management of Human Capital/Information Technology/ResourcesMission and Business ResultsReporting and InformationNumber of weakness citations (qualified opinions) resulting from annual external audit of FDA finanical books.000
22006Effective Management of Human Capital/Information Technology/ResourcesCustomer ResultsCustomer Satisfaction% user fee customer satisfaction with online service758078
32006Effective Management of Human Capital/Information Technology/ResourcesProcesses and ActivitiesFinancial ManagementNumber of weakness qualifiers resulting from annual external audit of FDA finanical books.000
42006Effective Management of Human Capital/Information Technology/ResourcesTechnologyOverall Costs% decrease in FDA financial transaction IT unit costs0 - prior to UFMS deployment on April 25, 2005-20
52007Effective Management of Human Capital/Information Technology/ResourcesMission and Business ResultsReporting and InformationNumber of weakness citations (qualified opinions) resulting from annual external audit of FDA finanical books.000 estimated as of 7/31/2007
62007Effective Management of Human Capital/Information Technology/ResourcesCustomer ResultsCustomer Satisfaction% user fee customer satisfaction with online service758279 estimated as of 7/31/2007
72007Effective Management of Human Capital/Information Technology/ResourcesProcesses and ActivitiesFinancial ManagementNumber of weakness citations (qualified opinions) resulting from annual external audit of FDA finanical books.000 estimated as of 7/31/2007
82007Effective Management of Human Capital/Information Technology/ResourcesTechnologyOverall Costs% decrease in FDA financial transaction IT unit costs0-2-5 estimated as of 7/31/2007
92008Effective Management of Human Capital/Information Technology/ResourcesMission and Business ResultsReporting and InformationNumber of weakness citations (qualified opinions) resulting from annual external audit of FDA finanical books.00TBD at end of the period.
102008Effective Management of Human Capital/Information Technology/ResourcesCustomer ResultsCustomer Satisfaction% user fee customer satisfaction with online service7581TBD at end of the period.
112008Effective Management of Human Capital/Information Technology/ResourcesProcesses and ActivitiesFinancial ManagementNumber of weakness citations (qualified opinions) resulting from annual external audit of FDA finanical books.00TBD at end of the period.
122008Effective Management of Human Capital/Information Technology/ResourcesTechnologyOverall Costs% decrease in FDA financial transaction IT unit costs0-3TBD at end of the period.
132009Effective Management of Human Capital/Information Technology/ResourcesMission and Business ResultsReporting and InformationNumber of weakness citations (qualified opinions) resulting from annual external audit of FDA finanical books.00TBD at end of the period.
142009Effective Management of Human Capital/Information Technology/ResourcesCustomer ResultsCustomer Satisfaction% user fee customer satisfaction with online service7583TBD at end of the period.
152009Effective Management of Human Capital/Information Technology/ResourcesProcesses and ActivitiesFinancial ManagementNumber of weakness citations (qualified opinions) resulting from annual external audit of FDA finanical books.00TBD at end of the period.
162009Effective Management of Human Capital/Information Technology/ResourcesTechnologyOverall Costs% decrease in FDA financial transaction IT unit costs0-4TBD at end of the period.
172010Effective Management of Human Capital/Information Technology/ResourcesMission and Business ResultsReporting and InformationNumber of weakness citations (qualified opinions) resulting from annual external audit of FDA finanical books.00TBD at end of the period.
182010Effective Management of Human Capital/Information Technology/ResourcesCustomer ResultsCustomer Satisfaction% user fee customer satisfaction with online service7584TBD at end of the period.
192010Effective Management of Human Capital/Information Technology/ResourcesProcesses and ActivitiesFinancial ManagementNumber of weakness citations (qualified opinions) resulting from annual external audit of FDA finanical books.00TBD at end of the period.
202010Effective Management of Human Capital/Information Technology/ResourcesTechnologyOverall Costs% decrease in FDA financial transaction IT unit costs0-5TBD at end of the period.
212011Effective Management of Human Capital/Information Technology/ResourcesMission and Business ResultsReporting and InformationNumber of weakness citations (qualified opinions) resulting from annual external audit of FDA finanical books.00TBD at end of the period.
222011Effective Management of Human Capital/Information Technology/ResourcesCustomer ResultsCustomer Satisfaction% user fee customer satisfaction with online service7585TBD at end of the period.
232011Effective Management of Human Capital/Information Technology/ResourcesProcesses and ActivitiesFinancial ManagementNumber of weakness citations (qualified opinions) resulting from annual external audit of FDA finanical books.00TBD at end of the period.
242011Effective Management of Human Capital/Information Technology/ResourcesTechnologyOverall Costs% decrease in FDA financial transaction IT unit costs0-6TBD at end of the period.
252012Effective Management of Human Capital/Information Technology/ResourcesMission and Business ResultsReporting and InformationNumber of weakness citations (qualified opinions) resulting from annual external audit of FDA finanical books.00TBD at end of the period.
262012Effective Management of Human Capital/Information Technology/ResourcesCustomer ResultsCustomer Satisfaction% user fee customer satisfaction with online service7586TBD at end of the period.
272012Effective Management of Human Capital/Information Technology/ResourcesProcesses and ActivitiesFinancial ManagementNumber of weakness citations (qualified opinions) resulting from annual external audit of FDA finanical books.00TBD at end of the period.
282012Effective Management of Human Capital/Information Technology/ResourcesTechnologyOverall Costs% decrease in FDA financial transaction IT unit costs0-7TBD at end of the period.
292013Effective Management of Human Capital/Information Technology/ResourcesMission and Business ResultsReporting and InformationNumber of weakness citations (qualified opinions) resulting from annual external audit of FDA finanical books.00TBD at end of the period.
302013Effective Management of Human Capital/Information Technology/ResourcesCustomer ResultsCustomer Satisfaction% user fee customer satisfaction with online service7587TBD at end of the period.
312013Effective Management of Human Capital/Information Technology/ResourcesProcesses and ActivitiesFinancial ManagementNumber of weakness citations (qualified opinions) resulting from annual external audit of FDA finanical books.00TBD at end of the period.
322013Effective Management of Human Capital/Information Technology/ResourcesTechnologyOverall Costs% decrease in FDA financial transaction IT unit costs0-8TBD at end of the period.

Enterprise Architecture


In order to successfully address this area of the business case and capital asset plan you must ensure the investment is included in the agency's EA and Capital Planning and Investment Control (CPIC) process, and is mapped to and supports the FEA. You must also ensure the business case demonstrates the relationship between the investment and the business, performance, data, services, application, and technology layers of the agency's EA.
1. Is this investment included in your agency's target enterprise architecture?
yes
2. Is this investment included in the agency's EA Transition Strategy?
yes
2.a. If yes, provide the investment name as identified in the Transition Strategy provided in the agency's most recent annual EA Assessment.
FDA Financial Enterprise Solutions
3. Is this investment identified in a completed (contains a target architecture) and approved segment architecture?
no
4. Identify the service components funded by this major IT investment (e.g., knowledge management, content management, customer relationship management, etc.). Provide this information in the format of the following table. For detailed guidance regarding components, please refer to http://www.whitehouse.gov/omb/egov/.

Component: Use existing SRM Components or identify as NEW. A NEW component is one not already identified as a service component in the FEA SRM.

Reused Name and UPI: A reused component is one being funded by another investment, but being used by this investment. Rather than answer yes or no, identify the reused service component funded by the other investment and identify the other investment using the Unique Project Identifier (UPI) code from the OMB Ex 300 or Ex 53 submission.

Internal or External Reuse?: Internal reuse is within an agency. For example, one agency within a department is reusing a service component provided by another agency within the same department. External reuse is one agency within a department reusing a service component provided by another agency in another department. A good example of this is an E-Gov initiative service being reused by multiple organizations across the federal government.

Funding Percentage: Please provide the percentage of the BY requested funding amount used for each service component listed in the table. If external, provide the funding level transferred to another agency to pay for the service.
RowAgency Component NameAgency Component DescriptionService TypeComponentReused Component NameReused UPIInternal or External Reuse?Funding %
1Activity-Based ManagementDefines the set of capabilities that support a defined, specific set of finance-related tasks for a given objective.Financial ManagementActivity-Based Management  No Reuse5
2Expense ManagementDefines the set of capabilities that support the management and reimbursement of costs paid by employees or an organization.Financial ManagementExpense Management  No Reuse25
3Billing and AccountingDefines the set of capabilities that support the charging, collection and reporting of an organization's accounts.Financial ManagementBilling and Accounting  No Reuse25
4Revenue ManagementDefines the set of capabilities that support the allocation and re-investment of earned net credit or capital within an organization.Financial ManagementRevenue Management  No Reuse5
5AuditingDefines the set of capabilities that support the examination and verification of records for accuracy.Financial ManagementAuditing  No Reuse15
6Internal ControlsSupport the methods and procedures used by the organization to safeguard its assets, produce accurate accounting data and reports, contribute to efficient operations, and encourage staff to adhere to management policies and mission requirementsFinancial ManagementInternal Controls  No Reuse25
5. To demonstrate how this major IT investment aligns with the FEA Technical Reference Model (TRM), please list the Service Areas, Categories, Standards, and Service Specifications supporting this IT investment.

FEA SRM Component: Service Components identified in the previous question should be entered in this column. Please enter multiple rows for FEA SRM Components supported by multiple TRM Service Specifications.

Service Specification: In the Service Specification field, Agencies should provide information on the specified technical standard or vendor product mapped to the FEA TRM Service Standard, including model or version numbers, as appropriate.
RowSRM Component>Service AreaService CategoryService StandardService Specification (i.e., vendor and product name)
1Activity-Based ManagementService Access and DeliveryService RequirementsHostingSun Microsystems
2Activity-Based ManagementService Access and DeliveryService RequirementsLegislative / ComplianceWeb Access
3Activity-Based ManagementComponent FrameworkData ManagementReporting and AnalysisBusiness Objects.
4Activity-Based ManagementComponent FrameworkData ManagementReporting and AnalysisCOBOL
5Activity-Based ManagementComponent FrameworkData ManagementReporting and AnalysisCompusearch
6Activity-Based ManagementComponent FrameworkData ManagementReporting and AnalysisGelco
7Activity-Based ManagementComponent FrameworkData ManagementReporting and AnalysisHyperion
8Activity-Based ManagementComponent FrameworkData ManagementReporting and AnalysisOracle
9Activity-Based ManagementComponent FrameworkData ManagementReporting and AnalysisPeopleSoft
10AuditingService Platform and InfrastructureDatabase / StorageStorageSun Servers
11AuditingService Platform and InfrastructureDatabase / StorageStorageCisco Servers
12AuditingComponent FrameworkData ManagementReporting and AnalysisBusiness Objects
13AuditingComponent FrameworkData ManagementReporting and AnalysisCOBOL
14AuditingComponent FrameworkData ManagementReporting and AnalysisCompusearch
15AuditingComponent FrameworkData ManagementReporting and AnalysisGelco
16AuditingComponent FrameworkData ManagementReporting and AnalysisHyperion
17AuditingComponent FrameworkData ManagementReporting and AnalysisOracle
18AuditingComponent FrameworkData ManagementReporting and AnalysisPeopleSoft
19Billing and AccountingService Platform and InfrastructureHardware / InfrastructureServers / ComputersOracle Financials 9i
20Billing and AccountingComponent FrameworkBusiness LogicPlatform DependentPeopleSoft
21Billing and AccountingComponent FrameworkData ManagementReporting and AnalysisBusiness Objects
22Billing and AccountingComponent FrameworkData ManagementReporting and AnalysisCOBOL
23Billing and AccountingComponent FrameworkData ManagementReporting and AnalysisCompusearch
24Billing and AccountingComponent FrameworkData ManagementReporting and AnalysisGelco
25Billing and AccountingComponent FrameworkData ManagementReporting and AnalysisHyperion
26Billing and AccountingComponent FrameworkData ManagementReporting and AnalysisOracle
27Billing and AccountingComponent FrameworkData ManagementReporting and AnalysisPeopleSoft
28Expense ManagementService Access and DeliveryAccess ChannelsWeb BrowserMS Internet Explorer
29Expense ManagementService Access and DeliveryAccess ChannelsOther Electronic ChannelsEthernet LAN
30Expense ManagementService Access and DeliveryAccess ChannelsOther Electronic ChannelsPointSec
31Expense ManagementService Access and DeliveryService RequirementsHostingSun Microsystems
32Expense ManagementService Platform and InfrastructureDatabase / StorageStorageSun Servers
33Expense ManagementService Platform and InfrastructureDatabase / StorageStorageCisco Servers
34Internal ControlsService Platform and InfrastructureHardware / InfrastructureServers / ComputersOracle Financials 9i
35Internal ControlsService Access and DeliveryAccess ChannelsWeb BrowserMS Internet Explorer
36Internal ControlsService Access and DeliveryAccess ChannelsCollaboration / CommunicationsBlackberry
37Internal ControlsService Access and DeliveryAccess ChannelsCollaboration / CommunicationsEmail
38Internal ControlsService Access and DeliveryDelivery ChannelsInternetWireless Cards
39Internal ControlsService Access and DeliveryDelivery ChannelsIntranetBlackberry
40Internal ControlsService Access and DeliveryService RequirementsHostingSun Microsystems
41Internal ControlsService Platform and InfrastructureDatabase / StorageStorageSun Servers
42Internal ControlsService Platform and InfrastructureDatabase / StorageStorageCisco Servers
43Revenue ManagementService Access and DeliveryAccess ChannelsCollaboration / CommunicationsEmail
44Revenue ManagementService Access and DeliveryDelivery ChannelsInternetWireless Cards
45Revenue ManagementService Access and DeliveryDelivery ChannelsIntranetBlackberry
46Revenue ManagementService Access and DeliveryService RequirementsHostingSun Microsystems
47Revenue ManagementService Platform and InfrastructureDatabase / StorageStorageSun Servers
48Revenue ManagementService Platform and InfrastructureDatabase / StorageStorageCisco Servers
6. Will the application leverage existing components and/or applications across the Government (i.e., FirstGov, Pay.Gov, etc)?
no

PART TWO


RISK


You should perform a risk assessment during the early planning and initial concept phase of the investment's life-cycle, develop a risk-adjusted life-cycle cost estimate and a plan to eliminate, mitigate or manage risk, and be actively managing risk throughout the investment's life-cycle.

Answer the following questions to describe how you are managing investment risks.
1. Does the investment have a Risk Management Plan?
yes
1.a. If yes, what is the date of the plan?
2007-06-30
1.b. Has the Risk Management Plan been significantly changed since last year's submission to OMB?
no
3. Briefly describe how investment risks are reflected in the life cycle cost estimate and investment schedule:
Investment risks and opportunity impacts were quantified by multiplying probability of occurence times the project cost impacts in terms of dollars. The resulting factors were used in cost estimates and schedules for the related work breakdown structure elements. As a result, both potential negative risks impacts as well as likely opportunities for improvements have been factored into both investment costs and scheduled.

COST & SCHEDULE


1. Does the earned value management system meet the criteria in ANSI/EIA Standard 748?
yes
2. Is the CV% or SV% greater than ± 10%?
no
3. Has the investment re-baselined during the past fiscal year?
no